Asarfi Hospital's Q1 FY26 investor presentation reveals robust performance.

Consolidated revenue surged 56% year-on-year to ₹35.68 Cr, with PAT more than doubling by 115% to ₹3.12 Cr.

EBITDA margin stood strong at 20%. Patient volumes increased 40%, and occupancy rates improved across both super-specialty (64%) and cancer hospitals (42%). A key development is the MoU with Gleneagles Hospital, Chennai, to establish Jharkhand's first multi-organ transplant unit, a move set to transform healthcare access in the region and enhance future growth prospects.